Synthesis and biological evaluation of novel imidazopyrimidin-3-amines as anticancer agents

Author:

Mahdavi Mohammad1,Dianat Shima2,Khavari Behnaz3,Moghimi Setareh4,Abdollahi Mohammad5,Safavi Maliheh6,Mouradzadegun Arash2,Kabudanian Ardestani Sussan3,Sabourian Reyhaneh7,Emami Saeed8,Akbarzadeh Tahmineh47,Shafiee Abbas4,Foroumadi Alireza14

Affiliation:

1. Drug Design and Development Research Center; Tehran University of Medical Sciences; Tehran Iran

2. Department of Chemistry; Faculty of Sciences; Shahid Chamran University; Ahvaz Iran

3. Institute of Biochemistry and Biophysics; Department of Biochemistry; University of Tehran; Tehran Iran

4. Department of Medicinal Chemistry; Faculty of Pharmacy and Pharmaceutical Sciences Research Center; Tehran University of Medical Sciences; Tehran Iran

5. Department of Toxicology and Pharmacology; Faculty of Pharmacy and Pharmaceutical Sciences Research Center; Tehran University of Medical Sciences; Tehran Iran

6. Department of Biotechnology; Iranian Research Organization for Science and Technology; Tehran Iran

7. Persian Medicine and Pharmacy Research Center; Tehran University of Medical Sciences; Tehran Iran

8. Department of Medicinal Chemistry and Pharmaceutical Sciences Research Center; Faculty of Pharmacy; Mazandaran University of Medical Sciences; Sari Iran

Funder

Tehran University of Medical Sciences and Health Services

Iran National Science Foundation

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3